Vatankhah Melody, Dadashzadeh Simin, Mahboubi Arash, Haeri Azadeh, Jandaghi Alaee Kimia, Mostafavi Naeini Seyed Baubak, Abbasian Zahra
Pharmaceutical Sciences Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Department of Pharmaceutics and Nanotechnology, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
J Liposome Res. 2024 Mar;34(1):77-87. doi: 10.1080/08982104.2023.2220805. Epub 2023 Jun 7.
Over the last few years, among controlled-release delivery systems, multivesicular liposomes (MVLs) have attracted attention due to their unique benefits as a loco-regional drug delivery system. Considering the clinical limitations of the current treatment strategies for osteomyelitis, MVLs can be a suitable carrier for the local delivery of effective antibiotics. This study aimed to prepare vancomycin hydrochloride (VAN HL) loaded MVLs using the active loading method which to the best of our knowledge has not been previously reported. Empty MVLS were prepared by the double emulsion (w/o/w) method and VAN HL was loaded into the prepared liposomes by the ammonium gradient method. After full characterization, the release profile of VAN HL from MVLs was assessed at two different pH values (5.5 and 7.4), and compared with the release profile of the free drug and also passively loaded MVLs. antimicrobial activities were evaluated using the disc diffusion method. Our results demonstrated that the encapsulation efficiency was higher than 90% in the optimum actively loaded MVL. The free VAN HL was released within 6-8 h, while the passively loaded MVLs and the optimum actively loaded MVL formulation released the drug in 6 days and up to 19 days, respectively. The released drug showed effective antibacterial activity against osteomyelitis-causing pathogens. In conclusion, the prepared formulation offered the advantages of sustained-release properties, appropriate particle size as well as being composed of biocompatible materials, and thus could be a promising candidate for the loco-regional delivery of VAN HL and the management of osteomyelitis.
在过去几年中,在控释给药系统中,多囊泡脂质体(MVL)作为一种局部区域给药系统因其独特优势而备受关注。考虑到目前骨髓炎治疗策略的临床局限性,MVL可作为局部递送有效抗生素的合适载体。本研究旨在采用活性载药法制备载有盐酸万古霉素(VAN HL)的MVL,据我们所知,此前尚未有相关报道。通过双乳液(w/o/w)法制备空白MVL,并采用铵梯度法将VAN HL载入制备好的脂质体中。在全面表征后,在两个不同pH值(5.5和7.4)下评估VAN HL从MVL中的释放曲线,并与游离药物以及被动载药MVL的释放曲线进行比较。采用纸片扩散法评估抗菌活性。我们的结果表明,在最佳活性载药的MVL中包封率高于90%。游离VAN HL在6 - 8小时内释放,而被动载药的MVL和最佳活性载药的MVL制剂分别在6天和长达19天内释放药物。释放的药物对引起骨髓炎的病原体显示出有效的抗菌活性。总之,所制备的制剂具有缓释特性、合适的粒径以及由生物相容性材料组成等优点,因此可能是VAN HL局部区域递送和骨髓炎治疗管理的有前景的候选者。